Rare Kidney Disease Show
av Travere Therapeutics
How Low Should Proteinuria Go? Complete Proteinuria Remission and…
Om denne podkasten
Welcome to the new Rare Kidney Disease Show part of the RKD Scientific Network sponsored by Travere Therapeutics. The Rare Kidney Disease Show is your primary source for cutting-edge insights, expert perspectives, and pivotal updates in nephrology. Led by our panel of experts, explore the advances in glomerular nephropathies through compelling conversations, challenging case studies, and discussions tackling hot topics. Join us as we strive to provide you with the ultimate resource to support your clinical practice and advance patient care.
Episoder
- How Low Should Proteinuria Go? Complete Proteinuria Remission and Kidney Function in IgA Nephropathy. · 30 min · Episode 11In this episode the Rare Kidney Disease Show, our host Chris Gisler is joined by Dr. Chee Kay Cheung from the University of Leicester to discuss the changing of proteinuria…
- Evolving Management of FSGS: Proteinuria and Clinical Data with Drs. Daniel Gale and Gaia Coppock · 29 min · Episode 10Welcome to Travere Therapeutics’ Rare Kidney Disease Show podcast, where rare kidney disease gets a spotlight. Host Dr. Chris Gisler, Senior Medical Director at Travere…
- Endothelin & Proteinuria in Glomerular Pathophysiology · 53 min · Episode 9Welcome to Travere Therapeutics’ Rare Kidney Disease podcast, where rare kidney disease gets a spotlight. Host Chris Gisler brings together two leading voices in nephrology, Dr…
- Insights from the SPARTAN Study with Drs. Jonathan Barratt and Shikha Wadhwani · 25 min · Episode 8In this episode, Drs. Jonathan Barratt and Shikha Wadhwani discuss findings from the SPARTAN study, a Phase 2 open-label, single-arm trial evaluating sparsentan in 12…
- From Podocyte to Patient: The Pathophysiology of FSGS · 29 min · Episode 7In this episode, Drs. Tobias Huber and Chris Gisler take a deep dive into the critical role of podocytes in kidney health and their involvement in the development and progression…
- Intro to FSGS - Dr. Howard Trachtman · 34 min · Episode 6Title: Intro to FSGS Episode Description: In this episode of the Rare Kidney Disease Show, Howard Trachtman, Adjunct Professor of Pediatrics at the University of Michigan, and…
- ASN Update - Sparsentan Redefining IgAN Treatment · 19 min · Episode 5In this episode of the Rare Kidney Disease Show, a panel of nephrology experts explore the latest data on sparsentan, as presented at ASN Kidney Week 2024. Dr. Hiddo Heerspink…
- Rethinking IgAN: A Different Perspective from Community Nephrologists : 4 · 16 min · Episode 4Luis Velez, MD is a board-certified community nephrologist in San Antonio, TX with expertise in hypertension and glomerular disorders. Jessica Coleman, MD is a board-certified…
- The Role of Endothelin in IgAN, ft. Dr. Donald Kohan : 3 · 17 min · Episode 3Episode Overview: Donald Kohan, PhD is an Emeritus Professor at the University of Utah Health with expertise in endothelin receptors, sodium transporters, and the…
- Unmet Needs in IgAN: Burden of Disease & Long-Term Impact on Patients ft. Dr. Jonathan Barratt : 2 · 16 min · Episode 2Overview: In this episode of the Rare Kidney Disease Show, Professor Jonathan Barratt discusses the need to take a long-term approach when managing IgA nephropathy patients. He…








